News and Views
Nature Cell Biology 10, 377 - 379 (2008)
doi:10.1038/ncb0408-377
BRCA1 and stem cells: tumour typecasting
Matthew J. Smalley1, Jorge S. Reis-Filho1 & Alan Ashworth1
-
Matthew J. Smalley, Jorge S. Reis-Filho and Alan Ashworth are at The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, Fulham Road, London, SW3 6JB, UK.
e-mail: Alan.Ashworth@icr.ac.uk
e-mail: Matthew.Smalley@icr.ac.uk
e-mail: Jorge.Reis-Filho@icr.ac.uk
Abstract
Phenotypic variation between tumour types is likely to reflect the nature of the cell of origin and the genes involved in pathogenesis. Compared with most sporadic breast cancers, those arising in carriers of BRCA1 mutations usually have distinctive pathological characteristics. A new study suggests that a role for BRCA1 in the determination of stem-cell fate may explain this phenomenon.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profileModern Pathology Original Article
Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotypeBritish Journal of Cancer Original Article
